Found: 21
Select item for more details and to access through your institution.
Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 7, p. 1157, doi. 10.1007/s00432-017-2389-3
- By:
- Publication type:
- Article
Efficacy of Neoadjuvant Chemohormonal Therapy in Oligometastatic Hormone-Sensitive Prostate Cancer: A Prospective, Three-Arm, Comparative Propensity Score Match Analysis.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. e223, doi. 10.1016/j.clgc.2021.02.004
- By:
- Publication type:
- Article
Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.963411
- By:
- Publication type:
- Article
Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221128356
- By:
- Publication type:
- Article
Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
E-cadherin bridges cell polarity and spindle orientation to ensure prostate epithelial integrity and prevent carcinogenesis in vivo.
- Published in:
- PLoS Genetics, 2018, v. 14, n. 8, p. 1, doi. 10.1371/journal.pgen.1007609
- By:
- Publication type:
- Article
Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 3, p. 969, doi. 10.4143/crt.2022.1557
- By:
- Publication type:
- Article
The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy.
- Published in:
- International Urology & Nephrology, 2023, v. 55, n. 6, p. 1447, doi. 10.1007/s11255-023-03560-x
- By:
- Publication type:
- Article
Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-01476-1
- By:
- Publication type:
- Article
The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 10, p. 1, doi. 10.1002/ctm2.527
- By:
- Publication type:
- Article
Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 6, p. 567, doi. 10.1002/pros.23762
- By:
- Publication type:
- Article
Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients.
- Published in:
- Prostate, 2018, v. 78, n. 4, p. 250, doi. 10.1002/pros.23465
- By:
- Publication type:
- Article
Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone.
- Published in:
- Prostate, 2017, v. 77, n. 12, p. 1233, doi. 10.1002/pros.23381
- By:
- Publication type:
- Article
Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancer.
- Published in:
- Prostate, 2017, v. 77, n. 13, p. 1373, doi. 10.1002/pros.23397
- By:
- Publication type:
- Article
Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2017, v. 120, n. 2, p. 226, doi. 10.1111/bju.13781
- By:
- Publication type:
- Article
HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 12, p. 3060, doi. 10.1002/ijc.33494
- By:
- Publication type:
- Article
The prognostic nomogram including MRI for locally advanced prostate cancer treated by radical prostatectomy.
- Published in:
- Prostate, 2021, v. 81, n. 8, p. 463, doi. 10.1002/pros.24126
- By:
- Publication type:
- Article
The Microbiome of Prostate Fluid Is Associated With Prostate Cancer.
- Published in:
- Frontiers in Microbiology, 2019, p. 1, doi. 10.3389/fmicb.2019.01664
- By:
- Publication type:
- Article
Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis.
- Published in:
- Medical Oncology, 2022, v. 39, n. 8, p. 1, doi. 10.1007/s12032-022-01648-5
- By:
- Publication type:
- Article
Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14296-y
- By:
- Publication type:
- Article